Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Johnson & Johnson vs. Eli Lilly: Which Healthcare Giant's Stock Is a Better Buy for 2027?

Eli Lilly's sales jumped 44.7% last year, while Johnson & Johnson's steadier profile raises a different question for cautious portfolios.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

Burnham Heads to COP31 Torn Between Cheaper Power and Net Zero

Andy Burnham will face difficult decisions on energy policy against the competing pressures of sky-high industrial costs and Labour’s net zero commitments.

  • Burnham must decide between cheaper power and net zero commitments
  • Chancellor prioritizes domestic energy costs over clean power
  • Gas field project raises questions about climate goals

More from Wednesday 11 November →